30.06.2021 13:00:00
|
Neo Announces Voting Results for the Election of Directors
TORONTO, June 30, 2021 /CNW/ - Neo Performance Materials Inc. (the "Company") (TSX: NEO) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management information circular dated May 28, 2021 for the 2021 Annual & Special Meeting of Shareholders (the "Meeting") were elected as directors of the Company. A total of 31,408,157 common shares were voted in person or by proxy, representing 82.94% of the outstanding common shares. Shareholders approved all items of business before the Meeting, including the election of directors as follows:
Nominee | Common Shares Voted | |
For | Withheld | |
Claire M.C. Kennedy | 99.32% | 0.68% |
Eric Noyrez | 96.25% | 3.75% |
Constantine E. Karayannopoulos | 95.22% | 4.78% |
Brook Hinchman | 92.79% | 7.21% |
Edgar Lee | 95.09% | 4.91% |
G. Gail Edwards | 99.90% | 0.10% |
Gregory Share | 92.99% | 7.01% |
About Neo Performance Materials
Neo Performance Materials is a global leader in the innovation and manufacturing of rare earth- and rare metal-based functional materials, which are essential inputs to high technology, high growth, future-facing industries. The business of the Company is organized along three segments: Magnequench, Chemicals & Oxides and Rare Metals. The Company is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, US; and Beijing, China. The Company operates globally with sales and production across 10 countries, being Japan, China, Thailand, Estonia, Singapore, Germany, United Kingdom, Canada, United States, and South Korea. For more information, please visit www.neomaterials.com.
SOURCE Neo Performance Materials, Inc.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Neogenomics IncShsmehr Nachrichten
21.10.24 |
Erste Schätzungen: Neogenomics stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
28.07.24 |
Ausblick: Neogenomics stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
14.07.24 |
Erste Schätzungen: Neogenomics stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |